Table 4.
Clinical features of agreeing samples between Hu 306 and PAM50 (n=117 with both mean-centring and DWD adjustment)
| Clinical factor | Molecular subtype | ||||
|---|---|---|---|---|---|
| Luminal A | Luminal B | Normal-breast like | Basal-like | HER2-enriched | |
| ER | |||||
| Positive | 35 | 15 | 2 | 0 | 3 |
| Negative | 0 | 1 | 4 | 39 | 18 |
| HER2 | |||||
| over-expressed | 2 | 5 | 2 | 2 | 18 |
| not over-expressed | 33 | 11 | 4 | 37 | 3 |
| Nuclear grade | |||||
| I | 17 | 0 | 1 | 0 | 0 |
| II | 16 | 4 | 2 | 2 | 4 |
| III | 2 | 12 | 3 | 37 | 17 |
| Nodal status | |||||
| Positive | 16 | 9 | 5 | 10 | 14 |
| Negative | 19 | 7 | 1 | 29 | 7 |
| Lymphovascular invasion* | |||||
| Positive | 14 | 11 | 4 | 11 | 13 |
| Negative | 21 | 5 | 2 | 28 | 8 |
*One missing value